Results 61 to 70 of about 60,702 (193)

Bilastine: new insight into antihistamine treatment

Clinical and Molecular Allergy, 2015
Bilastine is a new second generation H1-antihistamine recently approved for the symptomatic treatment of allergic rhinitis (AR) and chronic urticaria (CU).
E. Ridolo, M. Montagni, L. Bonzano, C. Incorvaia, G. Canonica   +4 more
semanticscholar   +1 more source

Pooled Analysis for the Effective and Safety of Leukotriene antagonist versus Selective H₁ antihistamine for Seasonal allergic rhinitis.

, 2014
LTRA, Leukotriene antagonist; SAH, Selective antihistamine; DNSS, Daytime nasal symptoms score; DESS, Daytime eye symptoms score; CSS, Composite symptoms score; NSS, Night-time symptoms score; RQOLS, Rhinoconjunctivitis quality-of-Life score.Pooled ...
Jun Wang (5906), Jixiang Zhang (553588), Yu Xu (52257)   +2 more
core   +1 more source

Antihistamine Potential of Red Alga Acanthophora spicifera Through Combination In Vivo, In Vitro, and In Silico Study

Indonesian Journal of Chemistry
Red alga Acanthophora spicifera is a marine species with potential as a source of natural antihistamines. This study evaluated the bioactivity of its secondary metabolites through in vivo, in vitro, and in silico approaches.
Ilmi Wahyuni, Nunuk Hariani Soekamto, Herlina Rasyid, Nurul Annisa, Risda Adriana, Alifiah Alfaniah Alfattah Putri, Djabal Nur Basir, Ahyar Ahmad, St. Fauziah, Rizal Irfandi   +9 more
doaj   +1 more source

Can Twitter Be a Source of Information on Allergy? Correlation of Pollen Counts with Tweets Reporting Symptoms of Allergic Rhinoconjunctivitis and Names of Antihistamine Drugs

PLoS ONE, 2015
Pollen forecasts are in use everywhere to inform therapeutic decisions for patients with allergic rhinoconjunctivitis (ARC). We exploited data derived from Twitter in order to identify tweets reporting a combination of symptoms consistent with a case ...
F. Gesualdo, Giovanni Stilo, A. D'Ambrosio, E. Carloni, E. Pandolfi, P. Velardi, A. Fiocchi, A. Tozzi   +7 more
semanticscholar   +1 more source

Generalized Bullous Fixed Drug Eruption Secondary to Levocetirizine: A Lesson Learned!

Clinical Case Reports
Fixed drug eruption (FDE) is a unique type of adverse drug eruption characterized by a well‐defined erythematous to violaceous patch that recurs at the same site upon re‐exposure to causative drugs and resolves with hyperpigmentation.
Mahesh Mathur, Sumit Paudel, Nabita Bhattarai, Sambidha Karki, Sandhya Regmi   +4 more
doaj   +1 more source

Protolytic Equilibria of Cetirizine in the Presence of Micelle-Forming Surfactants

Organics
The acid–base equilibria of cetirizine were investigated with and without the presence of differently charged micelle-forming surfactants (anionic, cationic, nonionic).
Marija Popović-Nikolić, Gordana Popović, Slavica Oljačić, Katarina Nikolić   +3 more
doaj   +1 more source

Eradication Therapy for Urticaria with High Titers of Anti H. pylori IgG Antibody

Allergology International, 2014
Background: It is known that idiopathic chronic urticaria occasionally develops with Helicobacter pylori (H. pylori) infection, but the association between urticaria and H. pylori remains unknown. Methods: We focused on the relationship between the titer
Takashi Yoshimasu, Fukumi Furukawa
doaj   +1 more source

Rupatadine: efficacy and safety of a non-sedating antihistamine with PAF-antagonist effects

Allergo Journal International, 2014
SummaryRupatadine is a modern non-sedating H1-antihistamine that also haswith additional antagonist effects on platelet-activating factor (PAF). Under the tradenames Rupafin® and Urtimed®, Rrupatadine is approvedregistered in Germany for the treatment of
Soja Shamizadeh, K. Brockow, J. Ring
semanticscholar   +1 more source

Double-Blind Placebo Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria

Journal of Allergy and Clinical Immunology: In Practice, 2014
Background Management of antihistamine refractory CIU has poorly defined therapeutic options. Objective To evaluate the efficacy of dapsone in antihistamine refractory CIU compared to placebo. Methods Twenty-two patients with antihistamine refractory CIU
M. Morgan, Andrew J. Cooke, L. Rogers, B. Adams-Huet, D. Khan   +4 more
semanticscholar   +1 more source

Night-time sedating H1-antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial

British Journal of Dermatology, 2014
Many physicians believe that the most effective way to treat chronic urticaria is to take a nonsedating second‐generation H1‐antihistamine in the morning and a sedating first‐generation H1‐antihistamine, usually hydroxyzine, at night to enhance sleep ...
M. Staevska, M. Gugutkova, C. Lazarova, T. Kralimarkova, V. Dimitrov, T. Zuberbier, M. K. Church, Todor A Popov   +7 more
semanticscholar   +1 more source